Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:46:41.480Z.
Calculation as of: 2026-10-06T14:46:41.480Z.
Quote observation: 2026-10-06T14:45:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a4fa98aa52f375fdc5874331a43a09dc7975e501838f67450551c218d6975f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-11-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
11.31x
EV/EBIT RATIO AVG 3Y
11.31x
EV/EBIT RATIO AVG 5Y
12.10x
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
EyePoint Pharmaceuticals, Inc.
Market Cap
$260.33M
EV/EBIT Ratio
N/A
TTM Avg
11.31x
3Y Avg
11.31x
5Y Avg
12.10x
Market Cap
$258.47M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.30M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$257.09M
EV/EBIT Ratio
N/A
TTM Avg
6.80x
3Y Avg
6.80x
5Y Avg
39.86x
Market Cap
$250.48M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$272.91M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $260.33M | N/A | 11.31x | 11.31x | 12.10x |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $258.47M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $258.00M | N/A | 17.57x | 14.15x | 16.75x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.09M | N/A | 6.80x | 6.80x | 39.86x |
| Century Therapeutics, Inc. (IPSC)vs › | $254.52M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $271.27M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | 98.16x | 1055.07x | 378.93x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2015-11-06 | 14.43x |
| 2015-11-05 | 15.02x |
| 2015-11-04 | 14.84x |
| 2015-11-03 | 14.61x |
| 2015-11-02 | 14.70x |
| 2015-10-30 | 14.61x |
| 2015-10-29 | 14.57x |
| 2015-10-28 | 14.66x |
| 2015-10-27 | 14.20x |
| 2015-10-26 | 14.70x |
| 2015-10-23 | 14.75x |
| 2015-10-22 | 14.98x |
| 2015-10-21 | 14.79x |
| 2015-10-20 | 15.34x |
| 2015-10-19 | 15.07x |
| 2015-10-16 | 15.21x |
| 2015-10-15 | 14.57x |
| 2015-10-14 | 13.83x |
| 2015-10-13 | 14.15x |
| 2015-10-12 | 14.43x |
| 2015-10-09 | 14.38x |
| 2015-10-08 | 14.06x |
| 2015-10-07 | 14.06x |
| 2015-10-06 | 14.43x |
| 2015-10-05 | 14.52x |
| 2015-10-02 | 13.88x |
| 2015-10-01 | 13.47x |
| 2015-09-30 | 13.74x |
| 2015-09-29 | 13.33x |
| 2015-09-28 | 14.38x |
| 2015-09-25 | 13.10x |
| 2015-09-24 | 13.56x |
| 2015-09-23 | 13.88x |
| 2015-09-22 | 13.97x |
| 2015-09-21 | 14.20x |
| 2015-09-18 | 14.75x |
| 2015-09-17 | 14.98x |
| 2015-09-16 | 14.25x |
| 2015-09-15 | 15.21x |
| 2015-09-14 | 14.57x |
| 2015-09-11 | 14.57x |
| 2015-09-10 | 11.47x |
| 2015-09-09 | 11.74x |
| 2015-09-08 | 11.66x |
| 2015-09-04 | 11.32x |
| 2015-09-03 | 11.32x |
| 2015-09-02 | 11.24x |
| 2015-09-01 | 11.24x |
| 2015-08-31 | 11.47x |
| 2015-08-28 | 12.21x |
| 2015-08-27 | 11.55x |
| 2015-08-26 | 11.63x |
| 2015-08-25 | 11.39x |
| 2015-08-24 | 11.66x |
| 2015-08-21 | 12.40x |
| 2015-08-20 | 12.52x |
| 2015-08-19 | 12.75x |
| 2015-08-18 | 12.63x |
| 2015-08-17 | 12.67x |
| 2015-08-14 | 12.63x |
| 2015-08-13 | 12.82x |
| 2015-08-12 | 12.82x |
| 2015-08-11 | 12.71x |
| 2015-08-10 | 12.63x |
| 2015-08-07 | 12.55x |
| 2015-08-06 | 12.59x |
| 2015-08-05 | 12.63x |
| 2015-08-04 | 12.71x |
| 2015-08-03 | 12.63x |
| 2015-07-31 | 12.67x |
| 2015-07-30 | 12.67x |
| 2015-07-29 | 13.13x |
| 2015-07-28 | 12.90x |
| 2015-07-27 | 12.82x |
| 2015-07-24 | 12.71x |
| 2015-07-23 | 12.79x |
| 2015-07-22 | 12.86x |
| 2015-07-21 | 12.98x |
| 2015-07-20 | 12.63x |
| 2015-07-17 | 12.63x |
| 2015-07-16 | 13.52x |
| 2015-07-15 | 13.67x |
| 2015-07-14 | 14.25x |
| 2015-07-13 | 13.60x |
| 2015-07-10 | 12.75x |
| 2015-07-09 | 12.13x |
| 2015-07-08 | 10.47x |
| 2015-07-07 | 11.24x |
| 2015-07-06 | 11.55x |
| 2015-07-02 | 11.63x |
| 2015-07-01 | 11.66x |
| 2015-06-30 | 11.55x |
| 2015-06-29 | 11.16x |
| 2015-06-26 | 11.70x |
| 2015-06-25 | 11.90x |
| 2015-06-24 | 12.44x |
| 2015-06-23 | 12.44x |
| 2015-06-22 | 12.55x |
| 2015-06-19 | 12.63x |
| 2015-06-18 | 12.52x |
| 2015-06-17 | 11.55x |
| 2015-06-16 | 11.51x |
| 2015-06-15 | 11.51x |
| 2015-06-12 | 11.78x |
| 2015-06-11 | 11.82x |
| 2015-06-10 | 11.86x |
| 2015-06-09 | 11.86x |
| 2015-06-08 | 12.17x |
| 2015-06-05 | 12.17x |
| 2015-06-04 | 11.94x |
| 2015-06-03 | 12.05x |
| 2015-06-02 | 11.86x |
| 2015-06-01 | 11.90x |
| 2015-05-29 | 12.17x |
| 2015-05-28 | 12.09x |
| 2015-05-27 | 11.97x |
| 2015-05-26 | 12.21x |
| 2015-05-22 | 12.48x |
| 2015-05-21 | 12.55x |
| 2015-05-20 | 12.55x |
| 2015-05-19 | 12.82x |
| 2015-05-18 | 12.40x |
| 2015-05-15 | 12.52x |
| 2015-05-14 | 12.59x |
| 2015-05-13 | 12.05x |
| 2015-05-12 | 12.24x |
| 2015-05-11 | 11.90x |
| 2015-05-08 | 8.20x |
| 2015-05-07 | 9.53x |
| 2015-05-06 | 9.50x |
| 2015-05-05 | 8.60x |
| 2015-05-04 | 8.57x |
| 2015-05-01 | 8.32x |
| 2015-04-30 | 8.29x |
| 2015-04-29 | 8.51x |
| 2015-04-28 | 8.60x |
| 2015-04-27 | 8.54x |
| 2015-04-24 | 8.85x |
| 2015-04-23 | 8.63x |
| 2015-04-22 | 8.51x |
| 2015-04-21 | 8.63x |
| 2015-04-20 | 8.57x |
| 2015-04-17 | 8.37x |
| 2015-04-16 | 8.57x |
| 2015-04-15 | 8.60x |
| 2015-04-14 | 8.65x |
| 2015-04-13 | 8.96x |
| 2015-04-10 | 8.79x |
| 2015-04-09 | 8.68x |
| 2015-04-08 | 8.46x |
| 2015-04-07 | 8.46x |
| 2015-04-06 | 8.34x |
| 2015-04-02 | 7.98x |
| 2015-04-01 | 7.98x |
| 2015-03-31 | 8.26x |
| 2015-03-30 | 8.32x |
| 2015-03-27 | 8.48x |
| 2015-03-26 | 8.60x |
| 2015-03-25 | 8.82x |
| 2015-03-24 | 9.41x |
| 2015-03-23 | 9.38x |
| 2015-03-20 | 9.24x |
| 2015-03-19 | 9.38x |
| 2015-03-18 | 9.33x |
| 2015-03-17 | 9.41x |
| 2015-03-16 | 9.30x |
| 2015-03-13 | 9.24x |
| 2015-03-12 | 9.50x |
| 2015-03-11 | 9.53x |
| 2015-03-10 | 9.47x |
| 2015-03-09 | 9.72x |
| 2015-03-06 | 9.72x |
| 2015-03-05 | 9.81x |
| 2015-03-04 | 10.00x |
| 2015-03-03 | 9.86x |
| 2015-03-02 | 9.81x |
| 2015-02-27 | 9.53x |
| 2015-02-26 | 9.72x |
| 2015-02-25 | 9.67x |
| 2015-02-24 | 9.69x |
| 2015-02-23 | 9.69x |
| 2015-02-20 | 9.81x |
| 2015-02-19 | 10.03x |
| 2015-02-18 | 9.64x |
| 2015-02-17 | 9.50x |
| 2015-02-13 | 8.93x |
| 2015-02-12 | 8.60x |
| 2015-02-11 | 8.57x |
| 2015-02-10 | 8.57x |
| 2015-02-09 | 8.57x |
| 2015-02-06 | 10.19x |
| 2015-02-05 | 9.80x |
| 2015-02-04 | 9.94x |
| 2015-02-03 | 9.80x |
| 2015-02-02 | 9.61x |
| 2015-01-30 | 9.77x |
| 2015-01-29 | 9.91x |
| 2015-01-28 | 9.97x |
| 2015-01-27 | 10.39x |
| 2015-01-26 | 10.33x |
| 2015-01-23 | 10.39x |
| 2015-01-22 | 10.30x |
| 2015-01-21 | 10.30x |
| 2015-01-20 | 10.44x |
| 2015-01-16 | 10.30x |
| 2015-01-15 | 10.11x |
| 2015-01-14 | 10.33x |
| 2015-01-13 | 10.05x |
| 2015-01-12 | 10.19x |
| 2015-01-09 | 10.33x |
| 2015-01-08 | 10.36x |
| 2015-01-07 | 10.25x |
| 2015-01-06 | 10.19x |
| 2015-01-05 | 10.42x |
| 2015-01-02 | 10.58x |
| 2014-12-31 | 10.44x |
| 2014-12-30 | 10.47x |
| 2014-12-29 | 10.47x |
| 2014-12-26 | 10.19x |
| 2014-12-24 | 10.14x |
| 2014-12-23 | 10.22x |
| 2014-12-22 | 10.75x |
| 2014-12-19 | 10.89x |
| 2014-12-18 | 10.75x |
| 2014-12-17 | 10.42x |
| 2014-12-16 | 10.39x |
| 2014-12-15 | 10.72x |
| 2014-12-12 | 11.25x |
| 2014-12-11 | 11.23x |
| 2014-12-10 | 11.59x |
| 2014-12-09 | 11.64x |
| 2014-12-08 | 11.17x |
| 2014-12-05 | 11.42x |
| 2014-12-04 | 11.03x |
| 2014-12-03 | 11.25x |
| 2014-12-02 | 11.25x |
| 2014-12-01 | 10.86x |
| 2014-11-28 | 11.00x |
| 2014-11-26 | 11.23x |
| 2014-11-25 | 10.86x |
| 2014-11-24 | 10.28x |
| 2014-11-21 | 9.86x |
| 2014-11-20 | 9.86x |
| 2014-11-19 | 8.96x |
| 2014-11-18 | 9.02x |
| 2014-11-17 | 8.99x |
| 2014-11-14 | 9.22x |
| 2014-11-13 | 8.94x |
| 2014-11-12 | 9.41x |
| 2014-11-11 | 9.05x |
| 2014-11-10 | 9.35x |
| 2011-09-13 | 29.72x |
| 2011-09-12 | 29.72x |
| 2011-09-09 | 30.69x |
| 2011-09-08 | 31.51x |
| 2011-09-07 | 31.34x |
| 2011-09-06 | 30.53x |
| 2011-09-02 | 30.77x |
| 2011-09-01 | 30.69x |
| 2011-08-31 | 30.86x |
Showing the most recent 260 of 684 data points. The chart above shows the full history.
